Secondary efficacy endpoints

Related by string. secondary efficacy endpoints * Secon dary . SECONDARY . secondary : Secondary Offering . Secondary School . Secondary Schools . Lasalle Secondary School / EFFICACY . Efficacy : primary efficacy endpoint . antimicrobial efficacy . preclinical efficacy / EndPoint . Endpoints . Endpoint : Secondary endpoints include . video conferencing endpoints . Secondary endpoints included * *

Related by context. Frequent words. (Click for all words.) 79 Secondary endpoints 69 secondary efficacy endpoints 69 Secondary endpoints include 68 Secondary endpoints included 68 secondary endpoints 64 achieved statistical significance 63 composite endpoint 63 echocardiographic 63 irbesartan 63 subgroup analyzes 63 pharmacodynamic 63 pharmacodynamic effects 63 univariate 62 concomitant medications 62 PREZISTA r 62 secondary endpoint 62 fasting plasma glucose 62 erythrocyte sedimentation rate 62 prespecified 61 active comparator 61 subscales 61 placebo controlled clinical 61 multivariate analyzes 61 Thrombolysis 61 PANSS 61 primary efficacy endpoints 61 glomerular filtration rate 61 IPSS 61 univariate analysis 61 lipid profiles 61 clinical endpoints 61 atherothrombosis 61 estimated glomerular filtration 61 carotid intima media 61 covariates 60 virologic response 60 ADAS cog 60 therapeutic regimens 60 primary efficacy endpoint 60 P = .# 60 haematological 60 tanespimycin 60 Response Evaluation Criteria 60 acute coronary syndromes ACS 60 Unified Parkinson Disease 60 HbA 1c 60 Negative Syndrome 60 #mg/day [001] 60 histopathological 60 DAS# [002] 60 ANOVA 60 noninferiority 60 subanalysis 60 apolipoprotein B 60 biochemical recurrence 59 comorbid conditions 59 HER2 positive metastatic breast 59 efficacy endpoints 59 preoperatively 59 SABCS 59 fasting insulin 59 RECIST criteria 59 evaluable 59 LUTS 59 HSCT 59 elotuzumab 59 HRQoL 59 COPD exacerbations 59 tolvaptan 59 cardiovascular morbidity 59 antihypertensive medications 59 NHANES III 59 HRQOL 59 Preoperative 59 6R BH4 59 sensitivity specificity 59 substudy 59 antiplatelet agents 59 lipid lowering therapy 59 liver transplant recipients 59 serum PSA 59 preoperative 59 serum uric acid 59 custirsen 58 AZOR 58 myocardial perfusion 58 MADRS 58 HbA1C 58 hypercholesterolemia 58 CI -#.# 58 % CI #.#-#.# [003] 58 HbA1c levels 58 angiotensin converting enzyme inhibitors 58 virologic 58 nonoperative 58 symptom severity 58 mRCC 58 hsCRP 58 creatinine clearance 58 fasting glucose levels 58 GSK# [001]

Back to home page